Article Versions Notes

Tobór-Świętek E, Sykut-Cegielska J, Bik-Multanowski M, Walczak M, Rokicki D, Kałużny Ł, Wierzba J, Pac M, Jahnz-Różyk K, Więsik-Szewczyk E, et al. COVID-19 Pandemic and Patients with Rare Inherited Metabolic Disorders and Rare Autoinflammatory Diseases—Organizational Challenges from the Point of View of Healthcare Providers. Journal of Clinical Medicine. 2021; 10(21):4862. https://doi.org/10.3390/jcm10214862

Tobór-Świętek, Ewa, Jolanta Sykut-Cegielska, Mirosław Bik-Multanowski, Mieczysław Walczak, Dariusz Rokicki, Łukasz Kałużny, Joanna Wierzba, Małgorzata Pac, Karina Jahnz-Różyk, Ewa Więsik-Szewczyk, and et al. 2021. "COVID-19 Pandemic and Patients with Rare Inherited Metabolic Disorders and Rare Autoinflammatory Diseases—Organizational Challenges from the Point of View of Healthcare Providers" Journal of Clinical Medicine 10, no. 21: 4862. https://doi.org/10.3390/jcm10214862

Tobór-Świętek, E., Sykut-Cegielska, J., Bik-Multanowski, M., Walczak, M., Rokicki, D., Kałużny, Ł., Wierzba, J., Pac, M., Jahnz-Różyk, K., Więsik-Szewczyk, E., & Kieć-Wilk, B. (2021). COVID-19 Pandemic and Patients with Rare Inherited Metabolic Disorders and Rare Autoinflammatory Diseases—Organizational Challenges from the Point of View of Healthcare Providers. Journal of Clinical Medicine, 10(21), 4862. https://doi.org/10.3390/jcm10214862